Avadel Pharmaceuticals (AVDL) Other Working Capital Changes: 2015-2022
Historic Other Working Capital Changes for Avadel Pharmaceuticals (AVDL) over the last 8 years, with Dec 2022 value amounting to -$3.0 million.
- Avadel Pharmaceuticals' Other Working Capital Changes fell 300100.00% to -$3.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$30.9 million, marking a year-over-year decrease of 3033.65%. This contributed to the annual value of -$828,000 for FY2024, which is 138.42% down from last year.
- Per Avadel Pharmaceuticals' latest filing, its Other Working Capital Changes stood at -$3.0 million for Q4 2022, which was up 79.50% from -$14.6 million recorded in Q3 2022.
- In the past 5 years, Avadel Pharmaceuticals' Other Working Capital Changes ranged from a high of $6.4 million in Q4 2018 and a low of -$15.4 million during Q2 2022.
- Over the past 3 years, Avadel Pharmaceuticals' median Other Working Capital Changes value was -$764,500 (recorded in 2020), while the average stood at -$2.6 million.
- Per our database at Business Quant, Avadel Pharmaceuticals' Other Working Capital Changes surged by 515.57% in 2021 and then slumped by 300,100.00% in 2022.
- Quarterly analysis of 5 years shows Avadel Pharmaceuticals' Other Working Capital Changes stood at $6.4 million in 2018, then crashed by 110.53% to -$672,000 in 2019, then skyrocketed by 84.52% to -$104,000 in 2020, then soared by 99.04% to -$1,000 in 2021, then slumped by 300,100.00% to -$3.0 million in 2022.
- Its Other Working Capital Changes was -$3.0 million in Q4 2022, compared to -$14.6 million in Q3 2022 and -$15.4 million in Q2 2022.